-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 G3VIwKJdhQrm3WBOzxKzz94c6EGlxDf2bI1RdfiLGXeIo4zex3aw1FYD+oQaw86j
 ZMVDHLiX8WbdCynp1Cv1Dg==

<SEC-DOCUMENT>0000897069-03-000648.txt : 20030612
<SEC-HEADER>0000897069-03-000648.hdr.sgml : 20030612
<ACCEPTANCE-DATETIME>20030612163206
ACCESSION NUMBER:		0000897069-03-000648
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20030611
ITEM INFORMATION:		Other events
ITEM INFORMATION:		Financial statements and exhibits
FILED AS OF DATE:		20030612

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NATIONAL RESEARCH CORP
		CENTRAL INDEX KEY:			0000070487
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-TESTING LABORATORIES [8734]
		IRS NUMBER:				470634000
		STATE OF INCORPORATION:			WI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29466
		FILM NUMBER:		03742405

	BUSINESS ADDRESS:	
		STREET 1:		1245 Q STREET
		CITY:			LINCOLN
		STATE:			NE
		ZIP:			68508
		BUSINESS PHONE:		4024752525

	MAIL ADDRESS:	
		STREET 1:		1245 Q STREET
		CITY:			LINCOLN
		STATE:			NE
		ZIP:			68508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>irm365.txt
<DESCRIPTION>FORM 8-K
<TEXT>
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                             _______________________

                                    FORM 8-K

                                 CURRENT REPORT


                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                             _______________________


                      Date of Report
                      (Date of earliest
                      event reported):        June 11, 2003


                          National Research Corporation
              ----------------------------------------------------
             (Exact name of registrant as specified in its charter)


   Wisconsin                        0-29466                      47-0634000
- ---------------                ----------------                --------------
(State or other                (Commission File                (IRS Employer
jurisdiction of                     Number)                 Identification No.)
incorporation)




                    1245 "Q" Street, Lincoln, Nebraska 68508
           ----------------------------------------------------------
          (Address of principal executive offices, including zip code)


                                 (402) 475-2525
                          -----------------------------
                         (Registrant's telephone number)



<PAGE>

Item 5.   Other Events and Required FD Disclosure.
- ------    ---------------------------------------

     On June 11, 2003, National Research Corporation issued a press release
announcing a modification to its contract with HealthSouth Corporation and
revising its earnings guidance for the second quarter of 2003. A copy of such
press release is furnished as Exhibit 99 and is incorporated by reference
herein.

Item 7.   Financial Statements and Exhibits.
- ------    ---------------------------------

          (a)  Not applicable.

          (b)  Not Applicable.

          (c)  Exhibits. The following exhibit is being furnished herewith:

               (99) Press Release of National Research Corporation, dated June
                    11, 2003.



                                      -2-

<PAGE>

                                   SIGNATURES
                                   ----------

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this amendment to the report to be signed on its
behalf by the undersigned hereunto duly authorized.


                                     NATIONAL RESEARCH CORPORATION



Date:  June 12, 2003                  By: /s/ Patrick E. Beans
                                         ---------------------------------------
                                         Patrick E. Beans
                                         Vice President, Treasurer, Secretary
                                          and Chief Financial Officer



                                      -3-

<PAGE>

                          NATIONAL RESEARCH CORPORATION

                   Exhibit Index to Current Report on Form 8-K
                               Dated June 11, 2003


Exhibit
Number
- ------

(99)        Press Release of National Research Corporation, dated June 11, 2003.



                                      -4-

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>irm365a.txt
<DESCRIPTION>PRESS RELEASE
<TEXT>
[GRAPHIC OMITTED][NATIONAL RESEARCH CORPORATION LOGO]            1245 "Q" Street
                                                               Lincoln, NE 68508
                                                             Phone: 402-475-2525
                                                               Fax: 402-475-9061

Contact: Patrick E. Beans
         Chief Financial Officer
         402-475-2525

           NATIONAL RESEARCH CORPORATION REVISES HEALTHSOUTH CONTRACT
                  ---------------------------------------------
          Company Revises Previously Announced Second Quarter Guidance
And Confirms Previously Announced Guidance for Third and Fourth Quarters of 2003

LINCOLN, Nebraska (June 11, 2003) -- National Research Corporation
(NASDAQ/NM:NRCI), today announced that it has reached an agreement to modify the
Company's current services contract with HealthSouth Corporation (formerly NYSE:
HRC; now OTC: HLSH). The modification to the contract will help ensure
HealthSouth remains a client, albeit at a reduced scope, by revising the payment
terms and reducing by 50% the services provided by the Company to HealthSouth.
As a result of the modified contract terms, National Research Corporation
received $250,000 towards $350,000 in invoices relating to current services, and
the Company will record a one-time charge in the second quarter of 2003 relating
to the unpaid $100,000 balance. The Company is revising its previously announced
guidance for the second quarter of 2003 from $0.16 per diluted share to $0.12
per diluted share as a result of the one-time charge and the reduction in the
scope of the HealthSouth project.

     While revenue from the HealthSouth contract will remain reduced in the
third and fourth quarters of 2003, the Company believes that new contracts
currently being awarded from other sources will offset the reduction in revenue
from HealthSouth. The Company expects second quarter 2003 revenue growth to meet
its 25% growth target. Given revenue growth trends, the Company's previously
announced guidance for the third and fourth quarters of 2003 remains $0.18 and
$0.19 per diluted share, respectively.

     In addition, under the terms of the new HealthSouth contract, National
Research Corporation will receive payment for future services in advance of
services being performed, thus reducing payment risk for the Company. The scope
of the project now reflects the minimum level of measurement mandatory for
accreditation purposes, minimizing the risk for additional reduction.
HealthSouth has also contractually agreed to name National Research Corporation
as its sole and exclusive provider of patient satisfaction measurement for their
facilities and is allowing the Company to contract directly with their
individual facilities for additional patient satisfaction measurement beyond the
minimum level required.

     National Research Corporation, headquartered in Lincoln, Nebraska, is a
leading provider of ongoing survey-based performance measurement, analysis and
tracking services to the healthcare industry. The Company addresses the growing
need of healthcare providers and payors to measure the care outcomes,
specifically satisfaction and health status, of their patients and/or members.

     This press release includes "forward-looking" statements related to the
Company that can generally be identified as describing the Company's future
plans, objectives or goals. Such forward-looking statements are subject to risks
and uncertainties that could cause actual results or outcomes to differ
materially from those currently anticipated. These forward-looking statements
are made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. For further information about the factors that
could affect the Company's future results, please see the Company's filings with
the Securities and Exchange Commission.

                                      -END-

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
